Form 4 Filing for Corcept Therapeutics Inc. - Officer Stock Transactions

This filing details stock transactions by Sean Maduck, an officer at Corcept Therapeutics Inc. On May 27, 2026, Maduck acquired 75,000 shares of Common Stock at a price of $8.27 per share, increasing his post-transaction holdings to 83,977 shares. This acquisition was linked to the exercise of a stock option. Additionally, Maduck disposed of 54,575 shares at a weighted average price of $65.3711 and 20,425 shares at a weighted average price of $66.1599. These sales were conducted under a 10b5-1 plan. The filing also notes various indirect holdings through trusts and LLCs, including shares held by Sean and Molly Maduck Living Trust, MMM 2025, LLC, SNM 2025 Grantor Retained Annuity Trust, SNM 2026 Grantor Retained Annuity Trust, and Duckhill Capital, LLC. Some of the shares are subject to vesting conditions as outlined in the footnotes.